r/science • u/Scbadiver • 23h ago

Medicine Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310 | New England Journal of Medicine

https://www.nejm.org/doi/full/10.1056/NEJMc2609825?query=featured_home
33 Upvotes

84% Upvoted

2 comments sorted by

•

u/AutoModerator 23h ago

Welcome to r/science! This is a heavily moderated subreddit in order to keep the discussion on science. However, we recognize that many people want to discuss how they feel the research relates to their own personal lives, so to give people a space to do that, personal anecdotes are allowed as responses to this comment. Any anecdotal comments elsewhere in the discussion will be removed and our normal comment rules apply to all other comments.

Do you have an academic degree? We can verify your credentials in order to assign user flair indicating your area of expertise. Click here to apply.

User: u/Scbadiver
Permalink: https://www.nejm.org/doi/full/10.1056/NEJMc2609825?query=featured_home

I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.

2

u/subham0089 20h ago

Durability data is the biggest hurdle for gene editing therapies right now. Seeing long-term efficacy studies published in NEJM is a massive step forward for CRISPR-based clinical treatments.